These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1358574)

  • 1. Disposition of metabolically labeled recombinant soluble CD4 (sT4) in male Sprague-Dawley rats following intravenous and subcutaneous administration.
    Davis CB; Boyle KE; Urbanski JJ; Paradysz RT; Fong KL
    Drug Metab Dispos; 1992; 20(5):695-705. PubMed ID: 1358574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley rats.
    Hepburn TW; Davis CB; Urbanski JJ; Smith BR; Schaefer WH; Carbonaro MA; Bugelski PJ
    Drug Metab Dispos; 1995 Oct; 23(10):1044-50. PubMed ID: 8654191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of metabolically radiolabeled CE9.1--a macaque-human chimeric anti-human CD4 monoclonal antibody--in transgenic mice bearing human CD4.
    Davis CB; Garver EM; Kwok DC; Urbanski JJ
    Drug Metab Dispos; 1996 Sep; 24(9):1032-7. PubMed ID: 8886616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic evaluation of drug interactions with anti-human immunodeficiency virus drugs. V. Effect of soluble CD4 on 2',3'-dideoxycytidine kinetics in monkeys.
    Qian M; Swagler AR; Fong KL; Crysler CS; Mehta M; Gallo JM
    Drug Metab Dispos; 1992; 20(3):396-401. PubMed ID: 1355714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to rats.
    Wasan KM; Peteherych KD; Najafi S; Zamfir C; Pritchard PH
    J Pharm Pharm Sci; 2001; 4(3):207-16. PubMed ID: 11737986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of mass balance, pharmacokinetics and disposition of [14C(U)]- and [125I]recombinant human interleukin-2 in cynomolgus monkeys.
    Nadeau RW; Satoh H; Scheide S; Crowl R; Conroy R; Garland WA; Liberato DJ
    Drug Metab Dispos; 1995 Sep; 23(9):904-9. PubMed ID: 8565779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of the 3H-labeled gonadotropin-releasing hormone analog buserelin in rats.
    Berger H; Sandow J; Heinrich N; Albrecht E; Kertscher U; Oehlke J
    Drug Metab Dispos; 1993; 21(5):818-22. PubMed ID: 7902242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats.
    Boyd BJ; Kaminskas LM; Karellas P; Krippner G; Lessene R; Porter CJ
    Mol Pharm; 2006; 3(5):614-27. PubMed ID: 17009860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 2nd communication: absorption, distribution and excretion after single and consecutive subcutaneous administration in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Tsutsumi S; Harada T; Miyoshi R; Inaba A
    Arzneimittelforschung; 1997 Feb; 47(2):195-200. PubMed ID: 9079240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of the pharmacokinetics of small proteins by iodination.
    Bauer RJ; Leigh SD; Birr CA; Bernhard SL; Fang M; Der K; Ihejeto NO; Carroll SF; Kung AH
    Biopharm Drug Dispos; 1996 Dec; 17(9):761-74. PubMed ID: 8968529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
    Fukano Y; Kawazu K
    Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats.
    Cossum PA; Sasmor H; Dellinger D; Truong L; Cummins L; Owens SR; Markham PM; Shea JP; Crooke S
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1181-90. PubMed ID: 8166890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of MK-852, a fibrinogen receptor antagonist, in rats and dogs.
    Vickers S; Duncan CA; Yuan AS; Vyas KP
    Drug Metab Dispos; 1994; 22(4):631-6. PubMed ID: 7956740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered pharmacokinetics of recombinant human deoxyribonuclease in rats due to the presence of a binding protein.
    Mohler M; Cook J; Lewis D; Moore J; Sinicropi D; Championsmith A; Ferraiolo B; Mordenti J
    Drug Metab Dispos; 1993; 21(1):71-5. PubMed ID: 8095230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma clearance and tissue distribution of partially thiolated polycytidylic acid and its degradation products in rodents.
    Kung MP; Ho YK; Lalka D; Bardos TJ
    Cancer Res; 1984 Oct; 44(10):4602-6. PubMed ID: 6467215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.